KRRO (Korro Bio) Tariff Resilience Score: 7/10 (As of Jul. 01, 2026)


KRRO Korro Bio Inc KRRO
6 GF Score
Price $13.18
! 5 Warning Signs
View Full Analysis

What is Korro Bio Tariff Resilience Score?

Korro Bio KRRO -0.11% 6 Tariff Resilience Score is 7 as of Jul. 01, 2026. GuruFocus rates KRRO with a GF Score™ of 6/100. The stock has 5 warning signs investors should review. Among 1,374 Biotechnology companies, Korro Bio ranks better than 90.39% on this metric.

Korro Bio has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

Korro Bio has Korro Bio Inc operates in the biotech sector, which is generally less vulnerable to tariffs. Its supply chain is primarily domestic, and it has not faced significant impacts from past tariff changes. The company can leverage its innovative capabilities and pricing power to mitigate potential tariff-related risks.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Korro Bio might have Highly Resilient.

Korro Bio  (NAS:KRRO) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Korro Bio Tariff Resilience Score Related Terms

KRRO vs LENZ, ANTX, OKUR: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Korro Bio's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Korro Bio Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Korro Bio's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Korro Bio's Tariff Resilience Score falls into.


KRRO
6GF Score
Korro Bio Inc KRRO
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
Korro Bio (KRRO) has a Tariff Resilience Score of 7 as of Jul. 01, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Korro Bio ranks #132 out of 1374 companies in the Biotechnology industry, placing it in the top 9.6%.
Is Korro Bio's Tariff Resilience Score too high?
Korro Bio's current Tariff Resilience Score is 7. The Biotechnology industry median Tariff Resilience Score is 4.00. Korro Bio's value of 7 is 75% above this industry median. Based on the distribution chart, Korro Bio ranks #132 out of 1374 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Korro Bio has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Korro Bio's Tariff Resilience Score compare to LENZ and ANTX?
According to the Biotechnology industry distribution chart, Korro Bio ranks #132 out of 1374 companies for Tariff Resilience Score. This places Korro Bio in the top 10% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Korro Bio's value of 7 is 75% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,374 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Korro Bio's current Tariff Resilience Score of 7 is 75% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Korro Bio's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Korro Bio stock overvalued right now?
Korro Bio (KRRO) has a current Tariff Resilience Score of 7. The current Tariff Resilience Score is 7 and 75% above the Biotechnology industry median of 4.00. Korro Bio's overall GF Score™ is 6/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Korro Bio (KRRO), the current Tariff Resilience Score is 7 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Korro Bio Business Description

Address 60 First Street, 2nd Floor, Suite 250, Cambridge, MA, USA, 02141
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
6GF Score

Get the complete analysis for KRRO

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.18
Price